Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Coagulation factor VIIIa |
Is a |
True |
Coagulation factor VIII |
Inferred relationship |
Some |
|
Factor VIII 250iu injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
|
Factor VIII 500iu injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
|
Factor VIII 1000iu injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
|
højrenset faktor VIII |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
|
højrenset faktor VIII-fraktion 250 IE, pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
|
højrenset faktor VIII-fraktion 500 IE, pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
|
højrenset faktor VIII-fraktion 1000 IE, pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
|
højrenset faktor VIII-fraktion 350 IE, pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
|
Factor VIII 250iu injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
|
Factor VIII 500iu injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
|
Factor VIII 1000iu injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
|
faktor VIII-fraktion-produkter |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
|
Coagulation factor VIII- and von Willebrand factor-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Coagulation factor VIII |
Inferred relationship |
Some |
2 |
faktor VIII 500 IE/von Willebrand-faktor 1100 IE, pulver og solvent til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
|
faktor VIII 1000 IE/von Willebrand-faktor 2200 IE, pulver og solvent til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
|
DNA-faktor VIII |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
|
intermediat faktor VIII |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
|
Product containing porcine factor VIII (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
|
Coagulation factor II- and coagulation factor IX- and coagulation factor VIIa- and coagulation factor VIII- and coagulation factor X-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Coagulation factor VIII |
Inferred relationship |
Some |
1 |
faktor VIII-bypassing-fraktion 500 IE, pulver og solvent til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
|
faktor VIII-bypassing fraktion 1000 IE, pulver og solvent til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
|
intermediat faktor VIII-fraktion 250 IE, pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
|
intermediat faktor VIII-fraktion 500 IE, pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
|
porcin faktor VIII 700 IE, pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
|
Coagulation factor VIII-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Coagulation factor VIII |
Inferred relationship |
Some |
1 |
faktor VIII 500 IE/von Willebrand-faktor 1250 IE, pulver til injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
|
faktor VIII 1000 IE/von Willebrand-faktor 2500 IE, pulver til injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
|
Octocog alfa (substance) |
Is a |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
|
Porcine factor VIII (substance) |
Is a |
True |
Coagulation factor VIII |
Inferred relationship |
Some |
|
bivirkning af faktor VIII-fraktion-produkter |
Causative agent |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
|
bivirkning af faktor VIII-bypassing fraktion-produkter |
Causative agent |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
|
allergi over for faktor VIII-fraktion-produkter |
Causative agent |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
|
Allergy to anti-inhibitor coagulant complex (finding) |
Causative agent |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
|
Antihaemophilic factor transfusion |
Direct substance |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
1 |
Antihaemophilic factor transfusion |
Direct substance |
True |
Coagulation factor VIII |
Inferred relationship |
Some |
1 |
Moroctocog alfa (substance) |
Is a |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
|
Allergy to anti-inhibitor coagulant complex (finding) |
Causative agent |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
1 |
allergi over for faktor VIII-fraktion-produkter |
Causative agent |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
1 |
Simoctocog alfa (substance) |
Is a |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
|
Efmoroctocog alfa (substance) |
Is a |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
|
Turoctocog alfa (substance) |
Is a |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
|
Lonoctocog alfa (substance) |
Is a |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
|
Factor VIII 500iu/von Willebrand factor 1100iu powder for conventional release solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
|
Factor VIII 1000iu/von Willebrand factor 2200iu powder for conventional release solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
|
Factor VIII adverse reaction (disorder) |
Causative agent |
True |
Coagulation factor VIII |
Inferred relationship |
Some |
1 |
Coagulation factor II and coagulation factor IX and coagulation factor VIIa and coagulation factor VIII and coagulation factor X only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Coagulation factor VIII |
Inferred relationship |
Some |
1 |
Coagulation factor VIII only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Coagulation factor VIII |
Inferred relationship |
Some |
1 |
Coagulation factor VIII and von Willebrand factor only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Coagulation factor VIII |
Inferred relationship |
Some |
2 |
Susoctocog alfa (substance) |
Is a |
False |
Coagulation factor VIII |
Inferred relationship |
Some |
|
Coagulation factor VIII and von Willebrand factor only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Coagulation factor VIII |
Inferred relationship |
Some |
2 |
Coagulation factor VIII 1000 unit and von Willebrand factor 2500 unit powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Coagulation factor VIII |
Inferred relationship |
Some |
2 |
Coagulation factor VIII 1000 unit and von Willebrand factor 2500 unit powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Coagulation factor VIII |
Inferred relationship |
Some |
2 |
Coagulation factor VIII 500 unit and von Willebrand factor 1250 unit powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Coagulation factor VIII |
Inferred relationship |
Some |
2 |
Coagulation factor VIII 500 unit and von Willebrand factor 1250 unit powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Coagulation factor VIII |
Inferred relationship |
Some |
2 |
Coagulation factor VIII- and von Willebrand factor-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Coagulation factor VIII |
Inferred relationship |
Some |
2 |
Product containing precisely coagulation factor VIII 500 unit/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Coagulation factor VIII |
Inferred relationship |
Some |
1 |
Product containing precisely coagulation factor VIII 500 unit/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Coagulation factor VIII |
Inferred relationship |
Some |
1 |
Product containing precisely coagulation factor VIII 250 unit/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Coagulation factor VIII |
Inferred relationship |
Some |
1 |
Product containing precisely coagulation factor VIII 250 unit/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Coagulation factor VIII |
Inferred relationship |
Some |
1 |
Product containing precisely coagulation factor VIII 1000 unit/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Coagulation factor VIII |
Inferred relationship |
Some |
1 |
Product containing precisely coagulation factor VIII 1000 unit/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Coagulation factor VIII |
Inferred relationship |
Some |
1 |
Coagulation factor VIII only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Coagulation factor VIII |
Inferred relationship |
Some |
1 |
Product containing coagulation factor VIII in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Coagulation factor VIII |
Inferred relationship |
Some |
1 |